PTAB
Advanced fields
299 decisions · 407msnewest first
  • PTAB · Sep 3, 2025 · IPR2025-00865 · APJ Coke Morgan Stewart · IPR · Director review

    The Director denied institution in IPR2025-00865 under § 314(a), citing the parallel ITC schedule, duplication risks, and Patent Owner’s settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date for each of these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-” slip op. at 2

    • Other 314aInstitution denied discretionary otherDenied

      “Petitioner argues that national security, economic, and public interest considerations counsel against discretionary denial because “[t]he semiconductor chips manufactured by TSMC are vital to leading U.S. companies (from Apple and NVIDIA to Amazon and Tesla) . . . and national security and defense through TSMC’s CyberShuttle program.” DD Opp. 31. Petitioner, however, does not explain in sufficient detail why review of the challenged patents is in the interest of national security, the economy, or the public. That is, Petitioner’s arguments are not narrowly-tailored towards particular products or manufacturing methods, and Petitioner does not sufficiently explain how national security, economic, or public interests warrant review of the specific patents challenged in these proceedings.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,147,747
  • PTAB · Sep 3, 2025 · IPR2025-00864 · APJ Coke Morgan Stewart · IPR · Director review

    The Director denied institution in IPR2025-00864 under § 314(a), finding the parallel ITC schedule and settled expectations favored discretionary denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date for each of these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-” slip op. at 2

    • Other 314aInstitution denied discretionary otherDenied

      “Petitioner argues that national security, economic, and public interest considerations counsel against discretionary denial because “[t]he semiconductor chips manufactured by TSMC are vital to leading U.S. companies (from Apple and NVIDIA to Amazon and Tesla) . . . and national security and defense through TSMC’s CyberShuttle program.” DD Opp. 31. Petitioner, however, does not explain in sufficient detail why review of the challenged patents is in the interest of national security, the economy, or the public. That is, Petitioner’s arguments are not narrowly-tailored towards particular products or manufacturing methods, and Petitioner does not sufficiently explain how national security, economic, or public interests warrant review of the specific patents challenged in these proceedings.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,184,292
  • PTAB · Sep 3, 2025 · IPR2025-00848 · APJ Coke Morgan Stewart · IPR · Director review

    The Director denied institution in IPR2025-00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 under § 314(a), citing ITC overlap and settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date for each of these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025- 1 Citations are to papers in IPR2025-00847. The parties filed similar papers in IPR2025-00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879. 00408, Paper 21 at 2–3 (Director June 18, 2025). These factors favor discretionary denial.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “these cases is November 15, 2026. The hearing in the parallel U.S. International Trade Commission (“ITC”) investigation is set for February 2, 2026. DD Req. 14. As such, it is unlikely that a final written decision in these proceedings will issue before the ITC trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. In addition, the patents challenged in IPR2025- 00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879 have been in force for seven, nine, nine, and ten years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources.  Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025- 1 Citations are to papers in IPR2025-00847. The parties filed similar papers in IPR2025-00848, IPR2025-00864, IPR2025-00865, and IPR2025-00879. 00408, Paper 21 at 2–3 (Director June 18, 2025). These factors favor discretionary denial.” slip op. at 2

    • Other 314aInstitution denied discretionary otherDenied

      “Petitioner argues that national security, economic, and public interest considerations counsel against discretionary denial because “[t]he semiconductor chips manufactured by TSMC are vital to leading U.S. companies (from Apple and NVIDIA to Amazon and Tesla) . . . and national security and defense through TSMC’s CyberShuttle program.” DD Opp. 31. Petitioner, however, does not explain in sufficient detail why review of the challenged patents is in the interest of national security, the economy, or the public. That is, Petitioner’s arguments are not narrowly-tailored towards particular products or manufacturing methods, and Petitioner does not sufficiently explain how national security, economic, or public interests warrant review of the specific patents challenged in these proceedings.” slip op. at 3

    • PTAB / AIA Trials › Discretionary denial › §325(d) same art / argumentsDenied

      “circumstances. In particular, Petitioner provides persuasive reasoning, supported by evidence, that the Office erred in a manner material to the patentability of the challenged patent during patent examination, and, accordingly, discretionary denial under 35 U.S.C. § 325(d) is not appropriate. Specifically, during prosecution of the challenged patent, the patent examiner applied Chien7702 to reject the claims, but subsequently allowed the claims after the applicant amended them. DD Opp. 5–6. Petitioner persuasively demonstrates that the patent examiner overlooked 2 US Pat. 6,815,770, Nov. 9, 2004 (Ex. 1037). certain teachings in Chien770 that appear to disclose the claimed features that the patent examiner indicated were not taught by the prior art of record, including Chien770. Id. at 7–10. Although the challenged patent has been in force for fifteen years, Petitioner appears to show a material error by the Office, and it is an appropriate use of Office resources to review the potential error.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,953,880
  • PTAB · Aug 29, 2025 · IPR2025-00836 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied the petitions under § 314(a), citing the trial schedule, duplication, expense, inconsistent-decision risk, and reexamination.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied

      “Other considerations favor discretionary denial. In particular, the projected final written decision due date in the Board proceeding is November 12, 2026. DD Req. 8; DD Opp. 12. The district court’s scheduled trial date is October 19, 2026, and the time-to-trial statistics suggest trial will begin in October 2026. DD Req. 8. As such, it is unlikely that a final written decision in this proceeding will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial. Furthermore, an ex parte reexamination request for one of the challenged patents is before the Office. Id. at 32. Under these circumstances, the considerations in favor of discretionary denial outweigh those that counsel against it.” slip op. at 2

    • Settled expectationsDenied

      “Some factors counsel against discretionary denial. For example, the challenged patents have not been in force for a significant period of time (issued in 2021 and 2023). Accordingly, Patent Owner has not developed strong settled expectations that favor discretionary denial as to these patents.” slip op. at 2

    • Other 314aDenied

      “Petitioner argues that national security interests counsel against discretionary denial because it is a “key supplier of critical networking infrastructure for government agencies and the military.” DD Opp. 5–7. Petitioner, however, does not explain in sufficient detail why review of the challenged patents is in the interest of national security. For example, Petitioner argues that it “provides network equipment to all four branches of the military.” Id. at 6. But Petitioner does not provide sufficient explanation as to how review of the challenged patents implicates national security interests beyond identifying that inter partes review of the challenged patents “frees up more of Cisco’s resources to be spent on critical national security and economic interests.” Id. at 5. Absent more, Petitioner’s argument does not tip the balance against discretionary denial. Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a).” slip op. at 3

    • Director reviewDirector review, deniedInstitution denied

      “to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trials are instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 11,816,249
  • PTAB · Aug 29, 2025 · IPR2025-00837 · APJ Coke Morgan Stewart · IPR · Director review

    The Director denied institution of IPR2025-00837 under § 314(a), finding the district court schedule, duplication risks, and pending reexamination favored discretionary denial.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “Other considerations favor discretionary denial. In particular, the projected final written decision due date in the Board proceeding is November 12, 2026. DD Req. 8; DD Opp. 12. The district court’s scheduled trial date is October 19, 2026, and the time-to-trial statistics suggest trial will begin in October 2026. DD Req. 8. As such, it is unlikely that a final written decision in this proceeding will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. Additionally, there is insufficient evidence that the district court is likely to stay its proceeding even if the Board were to institute trial. Furthermore, an ex parte reexamination request for one of the challenged patents is before the Office. Id. at 32. Under these circumstances, the considerations in favor of discretionary denial outweigh those that counsel against it.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “Some factors counsel against discretionary denial. For example, the challenged patents have not been in force for a significant period of time (issued in 2021 and 2023). Accordingly, Patent Owner has not developed strong settled expectations that favor discretionary denial as to these patents.” slip op. at 2

    • Other 314aInstitution denied discretionary otherDenied

      “Petitioner argues that national security interests counsel against discretionary denial because it is a “key supplier of critical networking infrastructure for government agencies and the military.” DD Opp. 5–7. Petitioner, however, does not explain in sufficient detail why review of the challenged patents is in the interest of national security. For example, Petitioner argues that it “provides network equipment to all four branches of the military.” Id. at 6. But Petitioner does not provide sufficient explanation as to how review of the challenged patents implicates national security interests beyond identifying that inter partes review of the challenged patents “frees up more of Cisco’s resources to be spent on critical national security and economic interests.” Id. at 5. Absent more, Petitioner’s argument does not tip the balance against discretionary denial. Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a).” slip op. at 3

    Discretionary denial
    Patents in suitUS 11,106,824
  • PTAB · Aug 14, 2025 · IPR2025-00693 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied institution under § 314(a), citing strong settled expectations and concerns about duplicative parallel litigation.

    RulingsDirector review decision
    • Settled expectationsDenied

      “approximately seventeen years and ten years, creating strong settled expectations for Patent Owner. Petitioner argues that it had settled expectations that the challenged patents would not be asserted against it because the previous patent owner2 never asserted the challenged patents. DD Opp. 3. Petitioner, however, acknowledges that it has been aware of Patent Owner’s patent portfolio in general since at least 2022, and the challenged patents specifically since 2023, after Patent Owner sent a series of letters to Petitioner identifying the challenged patents. In a letter dated December 1, 2023, Petitioner stated that it did “not believe it requires a license to any of the Identified Arkose Patents.” Ex. 1015, 2. Therefore, Petitioner had apparently evaluated the challenged patents as of that date but does not provide a sufficient explanation as to why that amounts to settled expectations. For example, a concession of non-infringement by a patent owner may constitute settled expectations for a petitioner. However, a petitioner’s reliance on its own assessment of patents presents a different 1 Citations are to papers in IPR2025-00693. The parties filed similar papers in IPR2025-00694. 2 Patent Owner acquired the challenged patents in 2021. See Ex. 1021. consideration. Under these circumstances, Petitioner’s assertions of settled expectations do not overcome Patent Owner’s strong settled expectations.” slip op. at 2

    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied

      “Furthermore, the parties are engaged in a parallel proceeding in district court. Although there is no scheduled trial date, which counsels against discretionary denial, Petitioner has not offered a stipulation to address concerns of duplicative efforts and potentially conflicting decisions, which weighs in favor of discretionary denial. On balance, the considerations that favor discretionary denial outweigh those that counsel against it.” slip op. at 3

    Discretionary denial
    Patents in suitUS 7,373,510
  • PTAB · Aug 14, 2025 · IPR2025-00683 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s request for discretionary denial and denied the petitions under § 314(a); no trial was instituted.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied

      “In particular, the projected final written decision due date in these Board proceedings is October 18, 2026. DD Req. 9–10. The district court’s scheduled trial date is June 22, 2026, and the time-to-trial statistics suggest trial will begin between May 2026 and January 2027. Id. at 22; DD Opp. 17–23. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions.” slip op. at 2

    • Settled expectationsInstitution denied

      “Furthermore, the challenged patents have been in force for thirteen and eleven years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025). Petitioner’s argument that Patent Owner does not have settled 1 Citations are to papers in IPR2025-00682. The parties filed similar papers in IPR2025-00683. expectations because Patent Owner did not previously assert the challenged patent against Petitioner does not defeat Patent Owner’s settled expectations. DD Opp. 38. Accordingly, in the absence of sufficient explanation, Patent Owner’s strong settled expectations tip the balance in favor of discretionary denial.” slip op. at 2

    Discretionary denial
    Patents in suitUS 8,907,425
  • PTAB · Aug 14, 2025 · IPR2025-00682 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied institution under § 314(a), citing trial timing, duplication risks, and Patent Owner’s settled expectations.

    RulingsDirector review decision
    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivDenied

      “In particular, the projected final written decision due date in these Board proceedings is October 18, 2026. DD Req. 9–10. The district court’s scheduled trial date is June 22, 2026, and the time-to-trial statistics suggest trial will begin between May 2026 and January 2027. Id. at 22; DD Opp. 17–23. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions.” slip op. at 2

    • Settled expectationsInstitution denied settled expectationsDenied

      “Furthermore, the challenged patents have been in force for thirteen and eleven years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide persuasive reasoning why an inter partes review is an appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025). Petitioner’s argument that Patent Owner does not have settled 1 Citations are to papers in IPR2025-00682. The parties filed similar papers in IPR2025-00683. expectations because Patent Owner did not previously assert the challenged patent against Petitioner does not defeat Patent Owner’s settled expectations. DD Opp. 38. Accordingly, in the absence of sufficient explanation, Patent Owner’s strong settled expectations tip the balance in favor of discretionary denial.” slip op. at 2

    • Other 314aInstitution denied discretionary otherDenied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 8,198,686
  • PTAB · Aug 14, 2025 · IPR2025-00659 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s discretionary-denial request and denied institution of the petitions under § 314(a), citing settled expectations, subsidiary ownership history, and parallel litigation.

    RulingsDirector review decision
    • Settled expectationsInstitution denied settled expectationsInstitution denied

      “wholly owned subsidiary of Petitioner, owned and maintained the challenged patents from 2015 until 2021. DD Opp. 4, 6; Ex. 1034; Paper 10, 1. Nuance further retained a license upon selling the patent that extended to its customers. DD Opp. 4, 6. Absent exceptional circumstances, it is not an appropriate use of Office resources where a party’s wholly owned subsidiary owned, maintained, sold, and retained a license for a patent, but, as is the case here, the party now advocates for its unpatentability. See Analog Devices, Inc. v. Number 14 B.V., IPR2025-00550, Paper 10 at 2 (Director July 16, 2025). Additionally, the challenged patents have been in force for more than fifteen, twelve, nine, thirteen, and eight years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide any persuasive reasoning why an inter partes review is an 1 Citations are to papers in IPR2025-00655. The parties filed similar papers in IPR2025-00656, IPR2025-00657, IPR2025-00658, and IPR2025-00659. appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025).” slip op. at 2

    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “Furthermore, one of Petitioner’s real-parties-in-interest, Bank of America, N.A., is a party to a parallel district court proceeding that involves the same challenged patents, the same challenged claims, and significantly overlapping invalidity contentions as these IPR proceedings. DD. Req. 15– 16; see Ex. 2003, 3, 60–76. The projected final written decision due date in these Board proceedings is in October 2026. DD Req. 6. The district court’s scheduled trial date is May 4, 2026. DD Opp. 15–16. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. This additionally weighs in favor of discretionary denial.” slip op. at 3

    • Other 314aInstitution denied discretionary otherInstitution denied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 9,495,957
  • PTAB · Aug 14, 2025 · IPR2025-00658 · APJ Coke Morgan Stewart · IPR · Director review

    The Director granted Patent Owner’s request for discretionary denial and denied institution under § 314(a), citing settled expectations, the subsidiary’s patent history, and parallel litigation.

    RulingsDirector review decision
    • Settled expectationsInstitution denied settled expectationsInstitution denied

      “wholly owned subsidiary of Petitioner, owned and maintained the challenged patents from 2015 until 2021. DD Opp. 4, 6; Ex. 1034; Paper 10, 1. Nuance further retained a license upon selling the patent that extended to its customers. DD Opp. 4, 6. Absent exceptional circumstances, it is not an appropriate use of Office resources where a party’s wholly owned subsidiary owned, maintained, sold, and retained a license for a patent, but, as is the case here, the party now advocates for its unpatentability. See Analog Devices, Inc. v. Number 14 B.V., IPR2025-00550, Paper 10 at 2 (Director July 16, 2025). Additionally, the challenged patents have been in force for more than fifteen, twelve, nine, thirteen, and eight years, respectively, creating strong settled expectations for Patent Owner, and Petitioner does not provide any persuasive reasoning why an inter partes review is an 1 Citations are to papers in IPR2025-00655. The parties filed similar papers in IPR2025-00656, IPR2025-00657, IPR2025-00658, and IPR2025-00659. appropriate use of Board resources. Dabico Airport Sols. Inc. v. AXA Power ApS, IPR2025-00408, Paper 21 at 2–3 (Director June 18, 2025).” slip op. at 2

    • PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Institution denied fintivInstitution denied

      “Furthermore, one of Petitioner’s real-parties-in-interest, Bank of America, N.A., is a party to a parallel district court proceeding that involves the same challenged patents, the same challenged claims, and significantly overlapping invalidity contentions as these IPR proceedings. DD. Req. 15– 16; see Ex. 2003, 3, 60–76. The projected final written decision due date in these Board proceedings is in October 2026. DD Req. 6. The district court’s scheduled trial date is May 4, 2026. DD Opp. 15–16. As such, it is unlikely that a final written decision in these proceedings will issue before district court trial occurs, resulting in significant duplication of effort, additional expense for the parties, and a risk of inconsistent decisions. This additionally weighs in favor of discretionary denial.” slip op. at 3

    • Other 314aInstitution denied discretionary otherInstitution denied

      “Although certain arguments are highlighted above, the determination to exercise discretion to deny institution is based on a holistic assessment of all of the evidence and arguments presented. Accordingly, the Petitions are denied under 35 U.S.C. § 314(a). In consideration of the foregoing, it is: ORDERED that Patent Owner’s request for discretionary denial is granted; and FURTHER ORDERED that the Petitions are denied, and no trial is instituted.” slip op. at 3

    Discretionary denial
    Patents in suitUS 8,195,468

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.